100 related articles for article (PubMed ID: 24527758)
21. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
22. Genetic Variations in Phospholipase C-epsilon 1 (PLCE1) and Susceptibility to Colorectal Cancer Risk.
Ezgi O; Merve A; Hakan YT; Gül Ö
Biochem Genet; 2016 Dec; 54(6):826-829. PubMed ID: 27383248
[TBL] [Abstract][Full Text] [Related]
23. The association of CYP2C9 gene polymorphisms with colorectal carcinoma in Han Chinese.
Liao LH; Zhang H; Lai MP; Lau KW; Lai AK; Zhang JH; Wang Q; Wei W; Chai JH; Lung ML; Tai SS; Wu M
Clin Chim Acta; 2007 May; 380(1-2):191-6. PubMed ID: 17368604
[TBL] [Abstract][Full Text] [Related]
24. [Association of the IL-18 gene polymorphism with susceptibility to colorectal cancer].
Guo JY; Qin AQ; Li RK; Yang CM; Huang FD; Huang ZY; Guo HJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Apr; 15(4):400-3. PubMed ID: 22539392
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
Tai J; Yang M; Ni X; Yu D; Fang J; Tan W; Huang Z; Wu C; Chen X; Wang G; Zhou W; Chen X; Zhang W; Ma L; Lin D; Han D
Cancer Genet Cytogenet; 2010 Jan; 196(1):76-82. PubMed ID: 19963139
[TBL] [Abstract][Full Text] [Related]
26. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
28. VEGF gene polymorphisms and susceptibility to colorectal cancer.
Jannuzzi AT; Özhan G; Yanar HT; Alpertunga B
Genet Test Mol Biomarkers; 2015 Mar; 19(3):133-7. PubMed ID: 25635747
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
30. CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese.
Darazy M; Balbaa M; Mugharbil A; Saeed H; Sidani H; Abdel-Razzak Z
Genet Test Mol Biomarkers; 2011 Jun; 15(6):423-9. PubMed ID: 21385088
[TBL] [Abstract][Full Text] [Related]
31. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
32. PTPRJ haplotypes and colorectal cancer risk.
Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
[TBL] [Abstract][Full Text] [Related]
33. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
[TBL] [Abstract][Full Text] [Related]
34. Telomerase Reverse Transcriptase (TERT) Gene Variations and Susceptibility of Colorectal Cancer.
Jannuzzi AT; Karaman E; Oztas E; Yanar HT; Özhan G
Genet Test Mol Biomarkers; 2015 Dec; 19(12):692-7. PubMed ID: 26501986
[TBL] [Abstract][Full Text] [Related]
35. Protective role of CYP1A1*2A in the development of multiple myeloma.
Kang SH; Kim TY; Kim HY; Yoon JH; Cho HI; Yoon SS; Kang DH; Suh CW; Lee JH; Lee DS
Acta Haematol; 2008; 119(1):60-4. PubMed ID: 18285692
[TBL] [Abstract][Full Text] [Related]
36. The Effect of the CYP1A1*2A Allele on Colorectal Cancer Susceptibility in a British Population.
Öztaş E; Özhan G; Daly AK
Genet Test Mol Biomarkers; 2016 Aug; 20(8):475-7. PubMed ID: 27243113
[TBL] [Abstract][Full Text] [Related]
37. Quantitative assessment of the effect of cytochrome P450 2C9 gene polymorphism and colorectal cancer.
Zhao Y; Han Y; Zhang L; Wang Y; Ma Y; Zhang F; Fu D; Wang X
PLoS One; 2013; 8(4):e60607. PubMed ID: 23577132
[TBL] [Abstract][Full Text] [Related]
38. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility.
Huang Y; Li X; He J; Chen L; Huang H; Liang M; Zhu Q; Huang Y; Wang L; Pan C; Xia T
World J Surg Oncol; 2015 Aug; 13():244. PubMed ID: 26271249
[TBL] [Abstract][Full Text] [Related]
40. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
